Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
Kim, S.T., Banks, K.C., Pectasides, E., Kim, S.Y., Kim, K., Lanman, R.B., Talasaz, A., An, J., Choi, M.G., Lee, J.H., Sohn, T.S., Bae, J.M., Kim, S., Park, S.H., Park, J.O., Park, Y.S., Lim, H.Y., Kim, N.K.D., Park, W., Lee, H., Bass, A.J., Kim, K., Kang, W.K., Lee, J.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma
Cho, J., Kim, S. Y., Kim, Y. J., Sim, M. H., Kim, S. T., Kim, N. K. D., Kim, K., Park, W., Kim, J. H., Jang, K.-T., Lee, J.
Published in Clinical & translational oncology (01.10.2017)
Published in Clinical & translational oncology (01.10.2017)
Get full text
Journal Article